| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smoking | 297 | 2023 | 1449 | 25.280 |
Why?
|
| Smoking Cessation | 225 | 2023 | 1032 | 25.080 |
Why?
|
| Tobacco Products | 87 | 2023 | 234 | 17.880 |
Why?
|
| Vaping | 64 | 2023 | 124 | 16.360 |
Why?
|
| Electronic Nicotine Delivery Systems | 80 | 2023 | 180 | 15.830 |
Why?
|
| Smoking Prevention | 91 | 2022 | 259 | 9.430 |
Why?
|
| Tobacco Use Disorder | 73 | 2022 | 432 | 8.830 |
Why?
|
| Tobacco Industry | 45 | 2021 | 55 | 7.710 |
Why?
|
| Nicotine | 67 | 2023 | 350 | 7.520 |
Why?
|
| Smokers | 51 | 2023 | 198 | 6.180 |
Why?
|
| Commerce | 41 | 2021 | 80 | 5.530 |
Why?
|
| Tobacco Smoke Pollution | 45 | 2022 | 127 | 5.320 |
Why?
|
| Tobacco | 58 | 2023 | 161 | 5.320 |
Why?
|
| Product Labeling | 30 | 2021 | 43 | 5.120 |
Why?
|
| United States | 195 | 2023 | 7335 | 4.520 |
Why?
|
| Canada | 76 | 2022 | 266 | 4.350 |
Why?
|
| Adult | 316 | 2023 | 21375 | 4.190 |
Why?
|
| Hotlines | 22 | 2017 | 51 | 4.180 |
Why?
|
| Intention | 17 | 2021 | 78 | 4.150 |
Why?
|
| Health Knowledge, Attitudes, Practice | 41 | 2020 | 766 | 3.970 |
Why?
|
| Australia | 68 | 2023 | 235 | 3.920 |
Why?
|
| Attitude to Health | 41 | 2019 | 403 | 3.800 |
Why?
|
| Humans | 510 | 2023 | 68525 | 3.760 |
Why?
|
| Adolescent | 180 | 2023 | 8903 | 3.430 |
Why?
|
| Health Promotion | 37 | 2017 | 407 | 3.400 |
Why?
|
| Cross-Cultural Comparison | 19 | 2020 | 68 | 3.350 |
Why?
|
| Young Adult | 121 | 2023 | 5708 | 3.240 |
Why?
|
| Cigarette Smoking | 16 | 2023 | 104 | 3.230 |
Why?
|
| Middle Aged | 243 | 2021 | 21119 | 3.210 |
Why?
|
| Tobacco Use | 28 | 2023 | 98 | 3.140 |
Why?
|
| Male | 303 | 2023 | 37281 | 2.950 |
Why?
|
| Female | 309 | 2021 | 38015 | 2.870 |
Why?
|
| United Kingdom | 47 | 2021 | 152 | 2.770 |
Why?
|
| Nicotinic Agonists | 14 | 2015 | 111 | 2.710 |
Why?
|
| Health Surveys | 32 | 2023 | 488 | 2.590 |
Why?
|
| Surveys and Questionnaires | 88 | 2022 | 2798 | 2.540 |
Why?
|
| Taxes | 18 | 2021 | 31 | 2.280 |
Why?
|
| Smoke-Free Policy | 6 | 2020 | 8 | 2.260 |
Why?
|
| Cross-Sectional Studies | 49 | 2022 | 2264 | 2.210 |
Why?
|
| Tobacco, Smokeless | 20 | 2020 | 40 | 2.200 |
Why?
|
| Public Health | 20 | 2022 | 201 | 2.180 |
Why?
|
| Motivation | 25 | 2020 | 561 | 2.120 |
Why?
|
| Health Education | 26 | 2019 | 279 | 2.000 |
Why?
|
| Health Policy | 27 | 2019 | 221 | 2.000 |
Why?
|
| New York | 72 | 2014 | 223 | 1.990 |
Why?
|
| Tobacco Smoking | 9 | 2022 | 41 | 1.910 |
Why?
|
| Lung Neoplasms | 16 | 2020 | 1172 | 1.880 |
Why?
|
| Neoplasms | 31 | 2020 | 1660 | 1.840 |
Why?
|
| Product Packaging | 11 | 2021 | 17 | 1.800 |
Why?
|
| Counseling | 14 | 2017 | 279 | 1.780 |
Why?
|
| Restaurants | 16 | 2022 | 29 | 1.720 |
Why?
|
| Consumer Product Safety | 10 | 2011 | 32 | 1.690 |
Why?
|
| Air Pollution, Indoor | 12 | 2019 | 26 | 1.690 |
Why?
|
| Longitudinal Studies | 44 | 2023 | 1054 | 1.660 |
Why?
|
| Housing | 9 | 2020 | 38 | 1.620 |
Why?
|
| Aged | 105 | 2022 | 14842 | 1.580 |
Why?
|
| Flavoring Agents | 15 | 2022 | 24 | 1.570 |
Why?
|
| Prevalence | 48 | 2021 | 1609 | 1.550 |
Why?
|
| Cohort Studies | 37 | 2022 | 2356 | 1.540 |
Why?
|
| Public Policy | 13 | 2021 | 71 | 1.520 |
Why?
|
| Consumer Behavior | 10 | 2020 | 68 | 1.500 |
Why?
|
| Socioeconomic Factors | 35 | 2020 | 955 | 1.460 |
Why?
|
| Tars | 9 | 2011 | 9 | 1.440 |
Why?
|
| Data Collection | 25 | 2014 | 420 | 1.400 |
Why?
|
| Public Opinion | 6 | 2014 | 32 | 1.200 |
Why?
|
| Harm Reduction | 10 | 2021 | 21 | 1.180 |
Why?
|
| Menthol | 7 | 2022 | 11 | 1.170 |
Why?
|
| England | 17 | 2021 | 64 | 1.170 |
Why?
|
| Marketing | 14 | 2019 | 26 | 1.170 |
Why?
|
| Behavior, Addictive | 10 | 2019 | 317 | 1.150 |
Why?
|
| Perception | 14 | 2023 | 189 | 1.140 |
Why?
|
| Self Efficacy | 7 | 2016 | 199 | 1.120 |
Why?
|
| Program Evaluation | 16 | 2012 | 502 | 1.080 |
Why?
|
| Cost-Benefit Analysis | 9 | 2021 | 503 | 1.040 |
Why?
|
| Quinoxalines | 5 | 2015 | 78 | 1.030 |
Why?
|
| Benzazepines | 5 | 2015 | 104 | 1.020 |
Why?
|
| Plants, Toxic | 14 | 2001 | 33 | 0.970 |
Why?
|
| Prospective Studies | 30 | 2022 | 3702 | 0.960 |
Why?
|
| Economics, Behavioral | 3 | 2019 | 12 | 0.960 |
Why?
|
| Internet | 7 | 2016 | 390 | 0.930 |
Why?
|
| Follow-Up Studies | 34 | 2019 | 3256 | 0.920 |
Why?
|
| Social Values | 4 | 2019 | 34 | 0.910 |
Why?
|
| Workplace | 10 | 2022 | 75 | 0.870 |
Why?
|
| Tobacco Use Cessation | 3 | 2018 | 44 | 0.850 |
Why?
|
| Adolescent Behavior | 9 | 2018 | 264 | 0.820 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2022 | 929 | 0.810 |
Why?
|
| Bias | 2 | 2012 | 148 | 0.810 |
Why?
|
| Health Behavior | 13 | 2021 | 458 | 0.800 |
Why?
|
| Health Care Costs | 6 | 2019 | 346 | 0.760 |
Why?
|
| Social Environment | 4 | 2019 | 182 | 0.760 |
Why?
|
| Environmental Exposure | 9 | 2012 | 269 | 0.750 |
Why?
|
| Hospitalization | 3 | 2017 | 977 | 0.750 |
Why?
|
| Cannabis | 2 | 2022 | 115 | 0.750 |
Why?
|
| Risk Reduction Behavior | 11 | 2017 | 174 | 0.720 |
Why?
|
| Risk | 16 | 2018 | 563 | 0.700 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 207 | 0.700 |
Why?
|
| Inhalation Exposure | 4 | 2017 | 33 | 0.680 |
Why?
|
| Time Factors | 36 | 2021 | 4655 | 0.660 |
Why?
|
| Self Report | 9 | 2021 | 370 | 0.660 |
Why?
|
| Age Factors | 28 | 2019 | 1860 | 0.650 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2012 | 467 | 0.650 |
Why?
|
| Bupropion | 3 | 2015 | 63 | 0.650 |
Why?
|
| Hospital Administration | 1 | 2018 | 43 | 0.630 |
Why?
|
| American Heart Association | 1 | 2018 | 142 | 0.620 |
Why?
|
| Costs and Cost Analysis | 6 | 2019 | 193 | 0.610 |
Why?
|
| Alcohol Drinking | 7 | 2012 | 805 | 0.610 |
Why?
|
| Recurrence | 15 | 2022 | 948 | 0.610 |
Why?
|
| Evidence-Based Practice | 1 | 2018 | 146 | 0.590 |
Why?
|
| Cotinine | 8 | 2015 | 40 | 0.580 |
Why?
|
| Medication Adherence | 2 | 2010 | 335 | 0.580 |
Why?
|
| Sex Factors | 19 | 2021 | 1265 | 0.580 |
Why?
|
| Social Stigma | 1 | 2017 | 53 | 0.580 |
Why?
|
| Policy Making | 5 | 2015 | 51 | 0.580 |
Why?
|
| Treatment Outcome | 18 | 2017 | 7028 | 0.580 |
Why?
|
| Smoke | 4 | 2022 | 46 | 0.570 |
Why?
|
| Mental Disorders | 2 | 2019 | 659 | 0.570 |
Why?
|
| Interviews as Topic | 14 | 2012 | 392 | 0.560 |
Why?
|
| Periodicals as Topic | 1 | 2018 | 158 | 0.540 |
Why?
|
| Early Detection of Cancer | 3 | 2019 | 439 | 0.540 |
Why?
|
| Odds Ratio | 8 | 2019 | 880 | 0.530 |
Why?
|
| Patient Readmission | 1 | 2018 | 267 | 0.530 |
Why?
|
| Disclosure | 1 | 2015 | 45 | 0.530 |
Why?
|
| Models, Statistical | 1 | 2019 | 446 | 0.520 |
Why?
|
| Awareness | 5 | 2015 | 81 | 0.510 |
Why?
|
| Filtration | 7 | 2017 | 61 | 0.500 |
Why?
|
| Patient Education as Topic | 5 | 2011 | 424 | 0.500 |
Why?
|
| Transdermal Patch | 2 | 2011 | 21 | 0.500 |
Why?
|
| Risk Factors | 28 | 2021 | 5719 | 0.480 |
Why?
|
| Varenicline | 6 | 2015 | 98 | 0.470 |
Why?
|
| Substance Withdrawal Syndrome | 5 | 2015 | 435 | 0.470 |
Why?
|
| Nonprescription Drugs | 3 | 2010 | 28 | 0.460 |
Why?
|
| Psychological Theory | 2 | 2012 | 27 | 0.460 |
Why?
|
| Environmental Monitoring | 7 | 2012 | 180 | 0.450 |
Why?
|
| Multivariate Analysis | 9 | 2017 | 1046 | 0.440 |
Why?
|
| Telephone | 4 | 2017 | 160 | 0.440 |
Why?
|
| Drug Utilization | 2 | 2011 | 119 | 0.440 |
Why?
|
| Colorectal Neoplasms | 6 | 2008 | 560 | 0.440 |
Why?
|
| Electronic Health Records | 4 | 2018 | 374 | 0.430 |
Why?
|
| Health Status Disparities | 2 | 2013 | 326 | 0.430 |
Why?
|
| Forecasting | 8 | 2019 | 277 | 0.430 |
Why?
|
| Population Surveillance | 7 | 2019 | 285 | 0.430 |
Why?
|
| International Cooperation | 7 | 2011 | 88 | 0.430 |
Why?
|
| Rationalization | 1 | 2012 | 1 | 0.430 |
Why?
|
| Cognitive Dissonance | 1 | 2012 | 4 | 0.420 |
Why?
|
| Carcinogens | 2 | 2013 | 86 | 0.410 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 1070 | 0.410 |
Why?
|
| Myocardial Infarction | 3 | 2013 | 807 | 0.410 |
Why?
|
| Risk Assessment | 16 | 2019 | 2004 | 0.410 |
Why?
|
| Alcoholism | 5 | 2014 | 1109 | 0.400 |
Why?
|
| Friends | 2 | 2022 | 33 | 0.400 |
Why?
|
| New York City | 10 | 2008 | 49 | 0.400 |
Why?
|
| Comprehension | 1 | 2011 | 71 | 0.400 |
Why?
|
| Directive Counseling | 2 | 2013 | 23 | 0.390 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2012 | 152 | 0.390 |
Why?
|
| Accidents | 1 | 2010 | 20 | 0.380 |
Why?
|
| Medicaid | 5 | 2011 | 301 | 0.380 |
Why?
|
| Income | 6 | 2019 | 165 | 0.380 |
Why?
|
| Fires | 1 | 2010 | 21 | 0.380 |
Why?
|
| Substance-Related Disorders | 5 | 2023 | 1241 | 0.370 |
Why?
|
| Patient Compliance | 12 | 2005 | 402 | 0.370 |
Why?
|
| Child | 27 | 2021 | 6400 | 0.370 |
Why?
|
| Prescription Drugs | 1 | 2010 | 71 | 0.360 |
Why?
|
| Mass Screening | 11 | 2019 | 837 | 0.360 |
Why?
|
| Secondary Prevention | 6 | 2015 | 291 | 0.350 |
Why?
|
| Reinforcement, Social | 1 | 2009 | 7 | 0.350 |
Why?
|
| Enzyme Inhibitors | 2 | 2003 | 659 | 0.350 |
Why?
|
| Mexico | 10 | 2019 | 38 | 0.350 |
Why?
|
| Europe | 3 | 2019 | 195 | 0.330 |
Why?
|
| Guideline Adherence | 4 | 2012 | 284 | 0.330 |
Why?
|
| Health Status | 5 | 2019 | 429 | 0.330 |
Why?
|
| Sex Distribution | 10 | 2016 | 272 | 0.320 |
Why?
|
| Japan | 4 | 2020 | 68 | 0.320 |
Why?
|
| Hospitals | 1 | 2010 | 265 | 0.320 |
Why?
|
| Risk-Taking | 5 | 2019 | 210 | 0.320 |
Why?
|
| Occult Blood | 6 | 2002 | 48 | 0.310 |
Why?
|
| Community Networks | 1 | 2008 | 96 | 0.310 |
Why?
|
| Social Behavior | 1 | 2009 | 164 | 0.310 |
Why?
|
| Occupational Exposure | 4 | 2010 | 122 | 0.310 |
Why?
|
| Age Distribution | 9 | 2014 | 319 | 0.300 |
Why?
|
| Community Participation | 5 | 2000 | 42 | 0.300 |
Why?
|
| Organizational Policy | 2 | 2005 | 42 | 0.300 |
Why?
|
| Aged, 80 and over | 16 | 2019 | 4843 | 0.300 |
Why?
|
| Self Concept | 1 | 2007 | 132 | 0.300 |
Why?
|
| Social Marketing | 4 | 2019 | 33 | 0.300 |
Why?
|
| Poverty | 6 | 2012 | 218 | 0.290 |
Why?
|
| Uruguay | 4 | 2019 | 4 | 0.290 |
Why?
|
| Cognition | 5 | 2021 | 512 | 0.290 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2019 | 300 | 0.290 |
Why?
|
| Inpatients | 2 | 2018 | 208 | 0.280 |
Why?
|
| Evidence-Based Medicine | 3 | 2018 | 438 | 0.280 |
Why?
|
| Head and Neck Neoplasms | 3 | 2022 | 561 | 0.280 |
Why?
|
| Occupational Health | 2 | 2005 | 41 | 0.280 |
Why?
|
| Advisory Committees | 2 | 2018 | 73 | 0.280 |
Why?
|
| Research Design | 6 | 2021 | 729 | 0.280 |
Why?
|
| Glass | 3 | 2000 | 28 | 0.280 |
Why?
|
| Internationality | 3 | 2011 | 74 | 0.270 |
Why?
|
| Attitude of Health Personnel | 5 | 2013 | 442 | 0.270 |
Why?
|
| Rectal Neoplasms | 5 | 1988 | 75 | 0.270 |
Why?
|
| Congresses as Topic | 1 | 2006 | 85 | 0.270 |
Why?
|
| Preventive Health Services | 3 | 2018 | 86 | 0.270 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2007 | 237 | 0.260 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 2323 | 0.260 |
Why?
|
| Cardiovascular Diseases | 3 | 2022 | 938 | 0.260 |
Why?
|
| Social Norms | 2 | 2023 | 3 | 0.260 |
Why?
|
| Pilot Projects | 9 | 2020 | 1341 | 0.250 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2013 | 503 | 0.250 |
Why?
|
| Physicians, Family | 5 | 2003 | 82 | 0.250 |
Why?
|
| Expert Testimony | 2 | 2021 | 47 | 0.240 |
Why?
|
| South Carolina | 4 | 2020 | 2750 | 0.240 |
Why?
|
| Consensus | 3 | 2018 | 211 | 0.240 |
Why?
|
| Indians, North American | 7 | 2005 | 64 | 0.240 |
Why?
|
| Employment | 4 | 2000 | 154 | 0.230 |
Why?
|
| Colonic Neoplasms | 5 | 1988 | 299 | 0.230 |
Why?
|
| New Zealand | 2 | 2020 | 28 | 0.230 |
Why?
|
| Social Class | 4 | 2012 | 127 | 0.230 |
Why?
|
| Asthma | 2 | 2021 | 345 | 0.230 |
Why?
|
| Attitude | 6 | 2014 | 121 | 0.220 |
Why?
|
| Pamphlets | 3 | 2015 | 27 | 0.220 |
Why?
|
| Capitalism | 1 | 2002 | 2 | 0.220 |
Why?
|
| Air Pollutants | 4 | 2010 | 75 | 0.220 |
Why?
|
| Taste | 3 | 2015 | 49 | 0.220 |
Why?
|
| Metals, Heavy | 2 | 2013 | 18 | 0.220 |
Why?
|
| Hot Temperature | 2 | 2019 | 152 | 0.220 |
Why?
|
| Logistic Models | 10 | 2019 | 1419 | 0.210 |
Why?
|
| Models, Theoretical | 3 | 2016 | 384 | 0.210 |
Why?
|
| United States Food and Drug Administration | 3 | 2022 | 131 | 0.210 |
Why?
|
| History, 20th Century | 3 | 2014 | 248 | 0.210 |
Why?
|
| Nitrosamines | 4 | 2013 | 18 | 0.210 |
Why?
|
| Mentha | 1 | 2021 | 4 | 0.210 |
Why?
|
| F2-Isoprostanes | 1 | 2021 | 14 | 0.210 |
Why?
|
| Education, Medical, Continuing | 1 | 2003 | 136 | 0.210 |
Why?
|
| Primary Health Care | 2 | 2020 | 702 | 0.200 |
Why?
|
| Drug and Narcotic Control | 2 | 1998 | 15 | 0.200 |
Why?
|
| Drug Labeling | 2 | 2019 | 32 | 0.200 |
Why?
|
| Drug Delivery Systems | 2 | 2013 | 236 | 0.200 |
Why?
|
| Demography | 5 | 2018 | 279 | 0.200 |
Why?
|
| Marketing of Health Services | 2 | 2000 | 18 | 0.200 |
Why?
|
| Netherlands | 5 | 2019 | 68 | 0.190 |
Why?
|
| Occupational Health Services | 2 | 1992 | 14 | 0.190 |
Why?
|
| Documentation | 6 | 2002 | 83 | 0.190 |
Why?
|
| Life Expectancy | 2 | 2019 | 51 | 0.190 |
Why?
|
| Hungary | 2 | 2010 | 10 | 0.190 |
Why?
|
| Peer Group | 2 | 2021 | 104 | 0.190 |
Why?
|
| Prognosis | 9 | 2014 | 2093 | 0.190 |
Why?
|
| Propylene Glycol | 1 | 2020 | 5 | 0.190 |
Why?
|
| Drug Therapy | 1 | 2020 | 71 | 0.190 |
Why?
|
| Glycerol | 1 | 2020 | 26 | 0.180 |
Why?
|
| Reproducibility of Results | 6 | 2021 | 2077 | 0.180 |
Why?
|
| Chemistry, Pharmaceutical | 2 | 2013 | 35 | 0.180 |
Why?
|
| Vegetables | 1 | 2020 | 76 | 0.180 |
Why?
|
| Personal Satisfaction | 1 | 2020 | 123 | 0.180 |
Why?
|
| Dual Use Research | 1 | 2019 | 2 | 0.180 |
Why?
|
| Antineoplastic Protocols | 1 | 2019 | 4 | 0.180 |
Why?
|
| Saliva | 5 | 2017 | 142 | 0.170 |
Why?
|
| Government Regulation | 4 | 2017 | 46 | 0.170 |
Why?
|
| Tobacco, Waterpipe | 1 | 2018 | 1 | 0.170 |
Why?
|
| Water Pipe Smoking | 1 | 2018 | 1 | 0.170 |
Why?
|
| Breast Neoplasms | 9 | 1995 | 1533 | 0.170 |
Why?
|
| Taste Perception | 2 | 2016 | 7 | 0.170 |
Why?
|
| Likelihood Functions | 1 | 2019 | 105 | 0.170 |
Why?
|
| Professional-Patient Relations | 1 | 2019 | 71 | 0.170 |
Why?
|
| Incidence | 4 | 2020 | 1582 | 0.170 |
Why?
|
| Research Report | 1 | 2018 | 35 | 0.170 |
Why?
|
| Delay Discounting | 1 | 2018 | 7 | 0.170 |
Why?
|
| Treatment Failure | 1 | 2019 | 216 | 0.170 |
Why?
|
| Asia | 2 | 2012 | 59 | 0.160 |
Why?
|
| Residence Characteristics | 4 | 2015 | 252 | 0.160 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 109 | 0.160 |
Why?
|
| Research | 5 | 2009 | 214 | 0.160 |
Why?
|
| Propaganda | 2 | 2011 | 3 | 0.160 |
Why?
|
| Administration, Cutaneous | 5 | 2007 | 56 | 0.150 |
Why?
|
| Ambulatory Care | 1 | 2020 | 339 | 0.150 |
Why?
|
| Latin America | 2 | 2010 | 19 | 0.150 |
Why?
|
| Thoracic Neoplasms | 1 | 2017 | 10 | 0.150 |
Why?
|
| Probability | 3 | 2021 | 244 | 0.150 |
Why?
|
| Cardiology | 1 | 2018 | 140 | 0.150 |
Why?
|
| Social Discrimination | 1 | 2017 | 8 | 0.150 |
Why?
|
| Adenocarcinoma | 2 | 2017 | 475 | 0.150 |
Why?
|
| Biomarkers | 6 | 2022 | 1593 | 0.150 |
Why?
|
| Oxidative Stress | 1 | 2021 | 718 | 0.150 |
Why?
|
| Craving | 2 | 2017 | 200 | 0.150 |
Why?
|
| Biomedical Research | 2 | 2010 | 310 | 0.150 |
Why?
|
| Mental Health | 1 | 2019 | 278 | 0.140 |
Why?
|
| Health Services Accessibility | 2 | 2012 | 581 | 0.140 |
Why?
|
| Pharmaceutical Preparations | 3 | 2006 | 100 | 0.140 |
Why?
|
| Crime | 1 | 1996 | 53 | 0.140 |
Why?
|
| Behavior | 4 | 2012 | 59 | 0.140 |
Why?
|
| Community Health Planning | 2 | 2006 | 19 | 0.140 |
Why?
|
| Public Facilities | 4 | 2007 | 7 | 0.140 |
Why?
|
| Linear Models | 3 | 2015 | 521 | 0.140 |
Why?
|
| Mass Media | 1 | 2015 | 29 | 0.130 |
Why?
|
| Databases, Factual | 1 | 2018 | 621 | 0.130 |
Why?
|
| Jurisprudence | 1 | 2015 | 11 | 0.130 |
Why?
|
| Age of Onset | 4 | 2008 | 188 | 0.130 |
Why?
|
| Health Care Surveys | 2 | 2017 | 239 | 0.130 |
Why?
|
| Registries | 3 | 2017 | 730 | 0.130 |
Why?
|
| Social Perception | 1 | 2015 | 44 | 0.130 |
Why?
|
| Medical Oncology | 2 | 2013 | 110 | 0.130 |
Why?
|
| Feasibility Studies | 1 | 2017 | 652 | 0.130 |
Why?
|
| Reward | 2 | 2018 | 201 | 0.130 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 447 | 0.130 |
Why?
|
| Culture | 2 | 2013 | 75 | 0.130 |
Why?
|
| Mouth Neoplasms | 2 | 2004 | 206 | 0.130 |
Why?
|
| Gender Identity | 1 | 2015 | 47 | 0.130 |
Why?
|
| Depressive Disorder | 1 | 2019 | 621 | 0.130 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2015 | 53 | 0.130 |
Why?
|
| Infant, Newborn | 1 | 2021 | 2453 | 0.130 |
Why?
|
| Educational Status | 3 | 2019 | 273 | 0.130 |
Why?
|
| Florida | 1 | 2015 | 221 | 0.130 |
Why?
|
| Students | 2 | 2007 | 233 | 0.130 |
Why?
|
| Comorbidity | 1 | 2019 | 1425 | 0.130 |
Why?
|
| Information Services | 2 | 1993 | 22 | 0.130 |
Why?
|
| Clinical Trials as Topic | 4 | 2012 | 848 | 0.130 |
Why?
|
| Decision Support Techniques | 1 | 2016 | 191 | 0.120 |
Why?
|
| Reagent Kits, Diagnostic | 5 | 1990 | 54 | 0.120 |
Why?
|
| United States Public Health Service | 1 | 2014 | 4 | 0.120 |
Why?
|
| Epidemiology | 1 | 2014 | 14 | 0.120 |
Why?
|
| Anniversaries and Special Events | 1 | 2014 | 12 | 0.120 |
Why?
|
| Testicular Neoplasms | 2 | 1985 | 27 | 0.120 |
Why?
|
| Neoplasms, Second Primary | 1 | 2014 | 61 | 0.120 |
Why?
|
| Arsenic | 1 | 2013 | 46 | 0.120 |
Why?
|
| Behavior Therapy | 3 | 2020 | 297 | 0.120 |
Why?
|
| Chi-Square Distribution | 5 | 2005 | 546 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 378 | 0.120 |
Why?
|
| Electronics | 1 | 2013 | 25 | 0.110 |
Why?
|
| Gingival Recession | 2 | 2008 | 4 | 0.110 |
Why?
|
| Algorithms | 1 | 2019 | 1194 | 0.110 |
Why?
|
| Administration, Intranasal | 1 | 2013 | 88 | 0.110 |
Why?
|
| Ethanol | 2 | 2019 | 892 | 0.110 |
Why?
|
| Palpation | 4 | 1985 | 21 | 0.110 |
Why?
|
| Carbon Monoxide | 2 | 2010 | 58 | 0.110 |
Why?
|
| Nutrition Surveys | 2 | 2021 | 204 | 0.110 |
Why?
|
| Renal Dialysis | 3 | 1984 | 174 | 0.110 |
Why?
|
| Administration, Oral | 2 | 2013 | 411 | 0.110 |
Why?
|
| China | 3 | 2019 | 138 | 0.110 |
Why?
|
| Health Literacy | 1 | 2012 | 62 | 0.110 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2012 | 4 | 0.110 |
Why?
|
| Australasia | 1 | 2012 | 2 | 0.110 |
Why?
|
| Respiratory Sounds | 2 | 2022 | 35 | 0.110 |
Why?
|
| History, 21st Century | 3 | 2019 | 126 | 0.110 |
Why?
|
| Depression | 2 | 2019 | 942 | 0.110 |
Why?
|
| Aspergillosis | 2 | 1989 | 20 | 0.100 |
Why?
|
| Cost Savings | 2 | 2011 | 110 | 0.100 |
Why?
|
| Referral and Consultation | 1 | 2014 | 383 | 0.100 |
Why?
|
| North America | 1 | 2012 | 111 | 0.100 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2012 | 33 | 0.100 |
Why?
|
| Hazardous Waste | 1 | 2011 | 14 | 0.100 |
Why?
|
| Color | 1 | 2011 | 50 | 0.100 |
Why?
|
| Public Housing | 1 | 2011 | 12 | 0.100 |
Why?
|
| Industry | 1 | 1991 | 28 | 0.100 |
Why?
|
| Hypersensitivity, Immediate | 1 | 1991 | 13 | 0.100 |
Why?
|
| Confidence Intervals | 2 | 2009 | 242 | 0.100 |
Why?
|
| Tax Exemption | 1 | 2011 | 4 | 0.100 |
Why?
|
| Legislation, Hospital | 1 | 2010 | 2 | 0.100 |
Why?
|
| Otitis Media | 1 | 1991 | 35 | 0.100 |
Why?
|
| Research Personnel | 1 | 1991 | 83 | 0.100 |
Why?
|
| Ontario | 1 | 2010 | 24 | 0.100 |
Why?
|
| Environment | 1 | 2011 | 115 | 0.090 |
Why?
|
| Chewing Gum | 2 | 2007 | 6 | 0.090 |
Why?
|
| Drug Approval | 2 | 2014 | 50 | 0.090 |
Why?
|
| Cross Infection | 2 | 1989 | 195 | 0.090 |
Why?
|
| Pyrrolidinones | 1 | 1990 | 15 | 0.090 |
Why?
|
| Temperance | 1 | 2010 | 41 | 0.090 |
Why?
|
| Baseball | 1 | 1989 | 6 | 0.090 |
Why?
|
| Regression Analysis | 5 | 2013 | 737 | 0.090 |
Why?
|
| Ownership | 1 | 2009 | 18 | 0.090 |
Why?
|
| Private Sector | 1 | 2009 | 18 | 0.090 |
Why?
|
| Gingival Diseases | 1 | 1989 | 22 | 0.090 |
Why?
|
| Gingivitis | 1 | 1989 | 16 | 0.090 |
Why?
|
| Work | 1 | 1989 | 12 | 0.090 |
Why?
|
| Health Plan Implementation | 1 | 2009 | 37 | 0.090 |
Why?
|
| Social Control, Formal | 2 | 2020 | 12 | 0.090 |
Why?
|
| Lung Diseases, Fungal | 1 | 1989 | 6 | 0.090 |
Why?
|
| Persuasive Communication | 1 | 2009 | 7 | 0.090 |
Why?
|
| Air Pollution | 1 | 1990 | 54 | 0.090 |
Why?
|
| Analysis of Variance | 4 | 2006 | 1039 | 0.090 |
Why?
|
| Licensure | 1 | 2009 | 18 | 0.090 |
Why?
|
| Leukemia, Myeloid | 1 | 1989 | 39 | 0.090 |
Why?
|
| Occupational Diseases | 1 | 1989 | 68 | 0.090 |
Why?
|
| Bangladesh | 2 | 2019 | 14 | 0.090 |
Why?
|
| Republic of Korea | 2 | 2019 | 23 | 0.090 |
Why?
|
| Biological Assay | 1 | 2009 | 88 | 0.090 |
Why?
|
| Parent-Child Relations | 2 | 1989 | 98 | 0.090 |
Why?
|
| Self Care | 3 | 1989 | 252 | 0.090 |
Why?
|
| Family Relations | 1 | 2009 | 47 | 0.090 |
Why?
|
| Delivery of Health Care | 2 | 2018 | 445 | 0.090 |
Why?
|
| Family Characteristics | 1 | 2009 | 44 | 0.080 |
Why?
|
| Universities | 2 | 2007 | 191 | 0.080 |
Why?
|
| Community Health Services | 2 | 2002 | 141 | 0.080 |
Why?
|
| Postal Service | 1 | 2008 | 19 | 0.080 |
Why?
|
| Teaching Materials | 1 | 1988 | 16 | 0.080 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2019 | 100 | 0.080 |
Why?
|
| Cultural Characteristics | 2 | 2004 | 42 | 0.080 |
Why?
|
| Newspapers as Topic | 1 | 1987 | 2 | 0.080 |
Why?
|
| Periodontal Diseases | 1 | 2008 | 54 | 0.080 |
Why?
|
| Emigrants and Immigrants | 1 | 2008 | 45 | 0.080 |
Why?
|
| Brain | 2 | 2015 | 2175 | 0.080 |
Why?
|
| Stress, Psychological | 2 | 2012 | 824 | 0.080 |
Why?
|
| Body Weight | 3 | 1987 | 554 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 951 | 0.080 |
Why?
|
| Choice Behavior | 1 | 1987 | 85 | 0.070 |
Why?
|
| Michigan | 7 | 1985 | 68 | 0.070 |
Why?
|
| Poverty Areas | 2 | 2003 | 20 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2022 | 1329 | 0.070 |
Why?
|
| Hypericum | 1 | 2006 | 6 | 0.070 |
Why?
|
| Genome, Human | 1 | 2006 | 62 | 0.070 |
Why?
|
| Chicago | 1 | 2006 | 30 | 0.070 |
Why?
|
| Global Health | 2 | 2006 | 135 | 0.070 |
Why?
|
| Nebraska | 2 | 2016 | 9 | 0.070 |
Why?
|
| Cough | 2 | 2022 | 65 | 0.070 |
Why?
|
| Malaysia | 2 | 2019 | 6 | 0.070 |
Why?
|
| Hypertension | 3 | 1985 | 1531 | 0.070 |
Why?
|
| Guilt | 2 | 2004 | 8 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2019 | 331 | 0.070 |
Why?
|
| Health | 2 | 2002 | 26 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2006 | 381 | 0.070 |
Why?
|
| Ganglionic Stimulants | 1 | 2005 | 15 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2006 | 284 | 0.070 |
Why?
|
| Appointments and Schedules | 1 | 1985 | 47 | 0.070 |
Why?
|
| Licensure, Pharmacy | 1 | 2005 | 1 | 0.070 |
Why?
|
| Evaluation Studies as Topic | 3 | 1998 | 219 | 0.060 |
Why?
|
| Causality | 2 | 2017 | 81 | 0.060 |
Why?
|
| Antidepressive Agents | 1 | 2006 | 216 | 0.060 |
Why?
|
| Patient Dropouts | 1 | 1985 | 98 | 0.060 |
Why?
|
| Ireland | 3 | 2009 | 13 | 0.060 |
Why?
|
| Scotland | 3 | 2009 | 18 | 0.060 |
Why?
|
| Mouthwashes | 1 | 2004 | 9 | 0.060 |
Why?
|
| Retrospective Studies | 7 | 2021 | 7264 | 0.060 |
Why?
|
| Guaiac | 1 | 1984 | 1 | 0.060 |
Why?
|
| Safety | 1 | 2005 | 145 | 0.060 |
Why?
|
| Physician-Patient Relations | 2 | 2003 | 261 | 0.060 |
Why?
|
| Drug Costs | 1 | 2005 | 87 | 0.060 |
Why?
|
| Hong Kong | 1 | 2004 | 11 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2020 | 1737 | 0.060 |
Why?
|
| Mortality | 3 | 1989 | 162 | 0.060 |
Why?
|
| Africa | 1 | 2004 | 41 | 0.060 |
Why?
|
| Health Personnel | 1 | 2006 | 286 | 0.060 |
Why?
|
| Pregnancy | 2 | 2021 | 2331 | 0.060 |
Why?
|
| Models, Psychological | 3 | 1981 | 180 | 0.060 |
Why?
|
| DNA | 2 | 2004 | 597 | 0.060 |
Why?
|
| Social Support | 3 | 2012 | 423 | 0.060 |
Why?
|
| Terminology as Topic | 2 | 2016 | 141 | 0.060 |
Why?
|
| Cooperative Behavior | 2 | 1999 | 235 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2006 | 866 | 0.050 |
Why?
|
| Patents as Topic | 1 | 2002 | 4 | 0.050 |
Why?
|
| Lobbying | 1 | 2002 | 11 | 0.050 |
Why?
|
| Budgets | 1 | 2002 | 12 | 0.050 |
Why?
|
| Peer Review | 1 | 2002 | 16 | 0.050 |
Why?
|
| Heart Diseases | 1 | 2004 | 276 | 0.050 |
Why?
|
| Infant | 5 | 2020 | 2891 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2015 | 714 | 0.050 |
Why?
|
| Cellulose | 1 | 2002 | 22 | 0.050 |
Why?
|
| Mammography | 2 | 1987 | 310 | 0.050 |
Why?
|
| Carbon Dioxide | 1 | 2002 | 78 | 0.050 |
Why?
|
| Environment Design | 1 | 2002 | 40 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 1982 | 91 | 0.050 |
Why?
|
| Diagnostic Tests, Routine | 1 | 1982 | 51 | 0.050 |
Why?
|
| Genetic Testing | 1 | 2003 | 159 | 0.050 |
Why?
|
| Parity | 1 | 2021 | 71 | 0.050 |
Why?
|
| Membranes, Artificial | 1 | 2002 | 88 | 0.050 |
Why?
|
| Cancer Care Facilities | 3 | 2003 | 32 | 0.050 |
Why?
|
| Consumer Advocacy | 1 | 2001 | 6 | 0.050 |
Why?
|
| Hazardous Substances | 2 | 2011 | 8 | 0.050 |
Why?
|
| Visual Perception | 1 | 2002 | 124 | 0.050 |
Why?
|
| Interprofessional Relations | 1 | 2002 | 188 | 0.050 |
Why?
|
| Models, Econometric | 1 | 2000 | 26 | 0.050 |
Why?
|
| Smoking Water Pipes | 1 | 2020 | 1 | 0.050 |
Why?
|
| Epidemiological Monitoring | 2 | 2010 | 23 | 0.050 |
Why?
|
| Deception | 1 | 2000 | 18 | 0.050 |
Why?
|
| Statistics, Nonparametric | 3 | 2006 | 306 | 0.050 |
Why?
|
| Non-Randomized Controlled Trials as Topic | 1 | 2019 | 19 | 0.050 |
Why?
|
| Public Health Surveillance | 1 | 2019 | 18 | 0.040 |
Why?
|
| Orthomyxoviridae Infections | 1 | 1979 | 4 | 0.040 |
Why?
|
| Solvents | 1 | 2020 | 108 | 0.040 |
Why?
|
| India | 1 | 2019 | 41 | 0.040 |
Why?
|
| Germany | 1 | 2019 | 67 | 0.040 |
Why?
|
| Propensity Score | 1 | 2019 | 116 | 0.040 |
Why?
|
| Zambia | 1 | 2019 | 8 | 0.040 |
Why?
|
| Informed Consent | 1 | 2000 | 127 | 0.040 |
Why?
|
| Brazil | 1 | 2019 | 48 | 0.040 |
Why?
|
| Physicians | 2 | 1984 | 324 | 0.040 |
Why?
|
| Drug Contamination | 1 | 1998 | 10 | 0.040 |
Why?
|
| Sexuality | 1 | 2018 | 12 | 0.040 |
Why?
|
| Geography | 1 | 2019 | 80 | 0.040 |
Why?
|
| Self-Assessment | 1 | 2019 | 69 | 0.040 |
Why?
|
| World Health Organization | 2 | 2010 | 53 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 785 | 0.040 |
Why?
|
| Education, Distance | 1 | 1998 | 34 | 0.040 |
Why?
|
| Mauritius | 1 | 2017 | 3 | 0.040 |
Why?
|
| Air Pollutants, Occupational | 2 | 2009 | 7 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2021 | 705 | 0.040 |
Why?
|
| Judgment | 2 | 1989 | 40 | 0.040 |
Why?
|
| Thailand | 1 | 2017 | 28 | 0.040 |
Why?
|
| Vaccination | 1 | 1979 | 182 | 0.040 |
Why?
|
| Students, Health Occupations | 1 | 1978 | 33 | 0.040 |
Why?
|
| Animals | 3 | 2013 | 20877 | 0.040 |
Why?
|
| Medical Informatics | 1 | 1998 | 71 | 0.040 |
Why?
|
| Respiration Disorders | 2 | 1989 | 20 | 0.040 |
Why?
|
| Needs Assessment | 1 | 1998 | 185 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 2 | 2016 | 201 | 0.040 |
Why?
|
| Hospitals, Special | 2 | 1988 | 15 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 2 | 1989 | 149 | 0.040 |
Why?
|
| Administration, Topical | 1 | 1997 | 111 | 0.040 |
Why?
|
| Outpatient Clinics, Hospital | 2 | 1988 | 69 | 0.040 |
Why?
|
| Medically Uninsured | 1 | 1997 | 99 | 0.040 |
Why?
|
| Decision Trees | 1 | 2016 | 74 | 0.040 |
Why?
|
| Cues | 2 | 2012 | 654 | 0.040 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2016 | 34 | 0.030 |
Why?
|
| Equipment Design | 1 | 2017 | 500 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2016 | 260 | 0.030 |
Why?
|
| Continuity of Patient Care | 1 | 2017 | 170 | 0.030 |
Why?
|
| Telemetry | 1 | 2015 | 23 | 0.030 |
Why?
|
| Functional Neuroimaging | 1 | 2015 | 82 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 1851 | 0.030 |
Why?
|
| Ornithine Decarboxylase | 1 | 1994 | 17 | 0.030 |
Why?
|
| Decision Making | 1 | 2018 | 410 | 0.030 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 1987 | 138 | 0.030 |
Why?
|
| Connecticut | 1 | 2014 | 13 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 1993 | 624 | 0.030 |
Why?
|
| Psychometrics | 1 | 2017 | 514 | 0.030 |
Why?
|
| Random Allocation | 3 | 2005 | 442 | 0.030 |
Why?
|
| Health Care Reform | 1 | 1994 | 62 | 0.030 |
Why?
|
| Sigmoidoscopy | 2 | 2002 | 38 | 0.030 |
Why?
|
| Health Services Research | 1 | 1995 | 209 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 567 | 0.030 |
Why?
|
| Carcinoma, Small Cell | 1 | 1993 | 53 | 0.030 |
Why?
|
| Developed Countries | 1 | 2013 | 8 | 0.030 |
Why?
|
| Legislation, Drug | 1 | 2013 | 9 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2014 | 113 | 0.030 |
Why?
|
| Surgical Wound Infection | 2 | 1992 | 168 | 0.030 |
Why?
|
| Television | 1 | 1993 | 28 | 0.030 |
Why?
|
| Breast | 2 | 1985 | 137 | 0.030 |
Why?
|
| Colonoscopy | 2 | 2002 | 156 | 0.030 |
Why?
|
| Interferons | 1 | 1993 | 36 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 1995 | 799 | 0.030 |
Why?
|
| National Institute on Alcohol Abuse and Alcoholism (U.S.) | 1 | 2012 | 2 | 0.030 |
Why?
|
| Automobiles | 1 | 1992 | 26 | 0.030 |
Why?
|
| Oncology Service, Hospital | 1 | 1992 | 9 | 0.030 |
Why?
|
| Disease Susceptibility | 3 | 1993 | 179 | 0.030 |
Why?
|
| Potassium | 2 | 1984 | 168 | 0.030 |
Why?
|
| History, 19th Century | 1 | 2012 | 95 | 0.030 |
Why?
|
| Child, Preschool | 5 | 1991 | 3185 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 1994 | 470 | 0.030 |
Why?
|
| Public Relations | 1 | 1991 | 2 | 0.030 |
Why?
|
| Emotions | 2 | 1985 | 244 | 0.030 |
Why?
|
| Family | 1 | 1993 | 293 | 0.020 |
Why?
|
| Research Support as Topic | 1 | 1991 | 58 | 0.020 |
Why?
|
| State Medicine | 1 | 2010 | 7 | 0.020 |
Why?
|
| Hemorrhoids | 1 | 1990 | 5 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 536 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2013 | 403 | 0.020 |
Why?
|
| Intestinal Polyps | 1 | 1990 | 15 | 0.020 |
Why?
|
| Ethics, Medical | 1 | 1991 | 86 | 0.020 |
Why?
|
| Stomach Ulcer | 1 | 1990 | 14 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 1990 | 95 | 0.020 |
Why?
|
| Carcinoma | 1 | 1992 | 215 | 0.020 |
Why?
|
| Mothers | 1 | 1992 | 172 | 0.020 |
Why?
|
| Diverticulum | 1 | 1990 | 29 | 0.020 |
Why?
|
| Economics | 1 | 1990 | 9 | 0.020 |
Why?
|
| Leasing, Property | 1 | 2009 | 1 | 0.020 |
Why?
|
| Colitis, Ulcerative | 1 | 1990 | 53 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2012 | 791 | 0.020 |
Why?
|
| Labor Unions | 1 | 1989 | 3 | 0.020 |
Why?
|
| Administrative Personnel | 1 | 1989 | 22 | 0.020 |
Why?
|
| Hospital Design and Construction | 1 | 1989 | 13 | 0.020 |
Why?
|
| Ventilation | 1 | 2009 | 3 | 0.020 |
Why?
|
| Air Movements | 1 | 2009 | 4 | 0.020 |
Why?
|
| Transplantation | 1 | 1989 | 23 | 0.020 |
Why?
|
| Quality of Life | 2 | 2012 | 1515 | 0.020 |
Why?
|
| Singapore | 1 | 2009 | 7 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 2 | 1984 | 365 | 0.020 |
Why?
|
| Acute Disease | 1 | 1991 | 658 | 0.020 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 1 | 2009 | 38 | 0.020 |
Why?
|
| Family Practice | 2 | 1990 | 312 | 0.020 |
Why?
|
| Sick Role | 1 | 1989 | 40 | 0.020 |
Why?
|
| Problem Solving | 1 | 1989 | 36 | 0.020 |
Why?
|
| Social Responsibility | 1 | 1989 | 39 | 0.020 |
Why?
|
| Dental Prophylaxis | 1 | 2008 | 7 | 0.020 |
Why?
|
| Periodontal Attachment Loss | 1 | 2008 | 12 | 0.020 |
Why?
|
| Periodontal Pocket | 1 | 2008 | 15 | 0.020 |
Why?
|
| Leukoplakia, Oral | 1 | 2008 | 12 | 0.020 |
Why?
|
| Oral Ulcer | 1 | 2008 | 22 | 0.020 |
Why?
|
| Observer Variation | 1 | 2009 | 330 | 0.020 |
Why?
|
| Focus Groups | 1 | 2009 | 247 | 0.020 |
Why?
|
| Oral Hygiene | 1 | 2008 | 33 | 0.020 |
Why?
|
| Physician's Role | 2 | 1990 | 116 | 0.020 |
Why?
|
| Pyridines | 1 | 2010 | 261 | 0.020 |
Why?
|
| Internal-External Control | 1 | 1988 | 60 | 0.020 |
Why?
|
| Periodontitis | 1 | 2008 | 47 | 0.020 |
Why?
|
| Tunisia | 1 | 2007 | 2 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2013 | 657 | 0.020 |
Why?
|
| Parents | 2 | 1988 | 309 | 0.020 |
Why?
|
| Tablets | 1 | 2007 | 19 | 0.020 |
Why?
|
| Romania | 1 | 2006 | 11 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 1990 | 1139 | 0.020 |
Why?
|
| Quality Control | 1 | 2007 | 81 | 0.020 |
Why?
|
| Adolescent Medicine | 1 | 1986 | 6 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2006 | 8 | 0.020 |
Why?
|
| Personality | 1 | 1987 | 66 | 0.020 |
Why?
|
| Genital Neoplasms, Female | 1 | 1986 | 37 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2006 | 95 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 2222 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2006 | 41 | 0.020 |
Why?
|
| Enema | 1 | 1986 | 23 | 0.020 |
Why?
|
| Self Administration | 2 | 1986 | 419 | 0.020 |
Why?
|
| Vitamin A | 1 | 1987 | 111 | 0.020 |
Why?
|
| Delphi Technique | 1 | 2005 | 62 | 0.020 |
Why?
|
| Toxins, Biological | 1 | 2005 | 23 | 0.020 |
Why?
|
| Barium Sulfate | 1 | 1986 | 66 | 0.020 |
Why?
|
| Government Programs | 1 | 2005 | 16 | 0.020 |
Why?
|
| Alleles | 1 | 2006 | 386 | 0.020 |
Why?
|
| Plant Extracts | 1 | 2006 | 122 | 0.020 |
Why?
|
| Irritable Mood | 1 | 1985 | 15 | 0.020 |
Why?
|
| Sleep Stages | 1 | 1985 | 30 | 0.020 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 1985 | 41 | 0.020 |
Why?
|
| Dizziness | 1 | 1985 | 27 | 0.020 |
Why?
|
| Respiration | 1 | 2005 | 91 | 0.020 |
Why?
|
| Mouth Diseases | 1 | 1985 | 38 | 0.020 |
Why?
|
| Constipation | 1 | 1985 | 32 | 0.020 |
Why?
|
| Epidemiologic Studies | 1 | 2004 | 33 | 0.020 |
Why?
|
| Eating | 1 | 1985 | 119 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2004 | 46 | 0.020 |
Why?
|
| Cause of Death | 3 | 1989 | 241 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2006 | 295 | 0.020 |
Why?
|
| Reference Values | 1 | 2005 | 579 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1987 | 444 | 0.020 |
Why?
|
| Massachusetts | 1 | 2003 | 28 | 0.010 |
Why?
|
| Education, Graduate | 1 | 1984 | 30 | 0.010 |
Why?
|
| Censuses | 1 | 2003 | 6 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2006 | 384 | 0.010 |
Why?
|
| Nurses | 1 | 1984 | 53 | 0.010 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 1985 | 91 | 0.010 |
Why?
|
| Fees and Charges | 1 | 1983 | 11 | 0.010 |
Why?
|
| Testis | 1 | 1983 | 37 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 492 | 0.010 |
Why?
|
| Pediatrics | 1 | 1986 | 341 | 0.010 |
Why?
|
| Clinical Laboratory Techniques | 1 | 1983 | 60 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2006 | 1548 | 0.010 |
Why?
|
| Urban Health | 1 | 1982 | 49 | 0.010 |
Why?
|
| Medical History Taking | 1 | 1983 | 94 | 0.010 |
Why?
|
| Local Government | 1 | 2002 | 17 | 0.010 |
Why?
|
| State Government | 1 | 2002 | 34 | 0.010 |
Why?
|
| Mother-Child Relations | 1 | 1982 | 43 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 785 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1986 | 1465 | 0.010 |
Why?
|
| Truth Disclosure | 1 | 2002 | 48 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 2002 | 122 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1982 | 219 | 0.010 |
Why?
|
| Alcoholic Intoxication | 1 | 1981 | 61 | 0.010 |
Why?
|
| Internship and Residency | 2 | 1990 | 596 | 0.010 |
Why?
|
| Mutation | 1 | 2006 | 1213 | 0.010 |
Why?
|
| Inflation, Economic | 1 | 2000 | 2 | 0.010 |
Why?
|
| Value of Life | 1 | 2000 | 14 | 0.010 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2000 | 29 | 0.010 |
Why?
|
| Urban Population | 1 | 1982 | 254 | 0.010 |
Why?
|
| Death Certificates | 2 | 1989 | 9 | 0.010 |
Why?
|
| Diet | 1 | 1983 | 513 | 0.010 |
Why?
|
| Politics | 1 | 1999 | 31 | 0.010 |
Why?
|
| Computer Literacy | 1 | 1998 | 9 | 0.010 |
Why?
|
| Psychological Tests | 1 | 1978 | 96 | 0.010 |
Why?
|
| Education, Nursing | 1 | 1998 | 55 | 0.010 |
Why?
|
| Hospital Bed Capacity, 100 to 299 | 2 | 1988 | 3 | 0.010 |
Why?
|
| Self Disclosure | 1 | 1997 | 55 | 0.010 |
Why?
|
| Liability, Legal | 1 | 1997 | 19 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2006 | 2688 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 1988 | 116 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 1982 | 778 | 0.010 |
Why?
|
| Receptors, Nicotinic | 1 | 1994 | 41 | 0.010 |
Why?
|
| Receptor, Insulin | 1 | 1994 | 71 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1994 | 223 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1994 | 379 | 0.010 |
Why?
|
| Life Style | 1 | 1995 | 338 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1993 | 94 | 0.010 |
Why?
|
| Glucose | 1 | 1994 | 307 | 0.010 |
Why?
|
| Learning | 1 | 1994 | 186 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 1993 | 94 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 1993 | 114 | 0.010 |
Why?
|
| Mastectomy, Segmental | 1 | 1992 | 63 | 0.010 |
Why?
|
| Mastectomy | 1 | 1992 | 56 | 0.010 |
Why?
|
| Rats | 1 | 2000 | 5300 | 0.010 |
Why?
|
| Drainage | 1 | 1992 | 133 | 0.010 |
Why?
|
| Infection Control | 1 | 1992 | 101 | 0.010 |
Why?
|
| Pharmacies | 1 | 1990 | 18 | 0.010 |
Why?
|
| Biopsy | 1 | 1992 | 539 | 0.010 |
Why?
|
| Actuarial Analysis | 1 | 1989 | 23 | 0.010 |
Why?
|
| Communicable Diseases | 1 | 1989 | 49 | 0.010 |
Why?
|
| Length of Stay | 1 | 1992 | 780 | 0.010 |
Why?
|
| Information Systems | 1 | 1988 | 45 | 0.000 |
Why?
|
| Urinary Tract Infections | 1 | 1988 | 71 | 0.000 |
Why?
|
| Bone Neoplasms | 1 | 1988 | 100 | 0.000 |
Why?
|
| Sampling Studies | 1 | 1987 | 80 | 0.000 |
Why?
|
| Respiratory Tract Infections | 1 | 1988 | 91 | 0.000 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1987 | 109 | 0.000 |
Why?
|
| Lymphoma | 1 | 1986 | 116 | 0.000 |
Why?
|
| Leukemia | 1 | 1986 | 117 | 0.000 |
Why?
|
| Air Microbiology | 1 | 1985 | 8 | 0.000 |
Why?
|
| Anemia, Aplastic | 1 | 1985 | 10 | 0.000 |
Why?
|
| Epidemiologic Methods | 1 | 1985 | 83 | 0.000 |
Why?
|
| Motion Pictures | 1 | 1985 | 8 | 0.000 |
Why?
|
| Disease Outbreaks | 1 | 1985 | 83 | 0.000 |
Why?
|
| Models, Anatomic | 1 | 1985 | 51 | 0.000 |
Why?
|
| Cytomegalovirus Infections | 1 | 1985 | 69 | 0.000 |
Why?
|
| Sepsis | 1 | 1988 | 233 | 0.000 |
Why?
|
| Feedback | 1 | 1985 | 90 | 0.000 |
Why?
|
| Writing | 1 | 1985 | 29 | 0.000 |
Why?
|
| Vitamins | 1 | 1985 | 134 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1988 | 334 | 0.000 |
Why?
|
| Methods | 1 | 1983 | 156 | 0.000 |
Why?
|
| Teaching | 1 | 1985 | 169 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1986 | 467 | 0.000 |
Why?
|
| Feeding Behavior | 1 | 1985 | 224 | 0.000 |
Why?
|
| Food | 1 | 1983 | 52 | 0.000 |
Why?
|
| Schools, Medical | 1 | 1984 | 157 | 0.000 |
Why?
|
| Mental Recall | 1 | 1983 | 72 | 0.000 |
Why?
|
| Anger | 1 | 1981 | 47 | 0.000 |
Why?
|
| Prostate | 1 | 1982 | 116 | 0.000 |
Why?
|
| Activities of Daily Living | 1 | 1983 | 319 | 0.000 |
Why?
|
| Life Change Events | 1 | 1981 | 223 | 0.000 |
Why?
|
| Affect | 1 | 1981 | 218 | 0.000 |
Why?
|